{
    "nct_id": "NCT03484299",
    "official_title": "Chemotherapy and Irreversible Electroporation (IRE) in the Treatment of Advanced Pancreatic Adenocarcinoma",
    "inclusion_criteria": "* greater than or equal to 18 years of age\n* diagnosed with stage III pancreatic cancer\n* tumor is measurable\n* GFR > mL/min/1.73m2\n* willing and able to comply with protocol requirements\n* AST/ALT >3 times upper limit of normal\n* stable surgical post-operative course as defined by operative surgeon\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* participating in another clinical trial for the treatment of cancer at the time of screening\n* pregnant or currently breast feeding\n* have a cardiac pacemaker or ICD implanted that cannot be deactivated during IRE procedure\n* have non-removable implants with metal parts within 1 cm of the target lesion\n* had a myocardial infarction within 3 months prior to enrollment",
    "miscellaneous_criteria": ""
}